基金重仓
Search documents
奥浦迈的前世今生:营收2.72亿行业排名28,净利润4905.68万行业排名18
Xin Lang Cai Jing· 2025-10-30 11:26
Core Viewpoint - Aopumai, a leading company in the cell culture products and services sector in China, has shown significant growth potential despite its current lower ranking in revenue and profit compared to industry leaders [1][2]. Group 1: Company Overview - Aopumai was established on November 27, 2013, and was listed on the Shanghai Stock Exchange on September 2, 2022, with its headquarters in Shanghai [1]. - The company operates in the pharmaceutical and biotechnology sector, specifically in the bioproducts category, and has a comprehensive industry chain and technological research advantages [1]. Group 2: Financial Performance - For Q3 2025, Aopumai reported revenue of 272 million yuan, ranking 28th out of 34 in the industry, significantly lower than the top competitors [2]. - The revenue composition includes product revenue of 155 million yuan (87.34%), service revenue of 22.27 million yuan (12.53%), and other revenue of 0.233 million yuan (0.13%) [2]. - The net profit for the same period was 49.06 million yuan, ranking 18th in the industry, again trailing behind leading companies [2]. Group 3: Financial Ratios - Aopumai's debt-to-asset ratio stood at 7.59% in Q3 2025, slightly up from 7.00% year-on-year, but well below the industry average of 26.88%, indicating strong solvency [3]. - The gross profit margin was reported at 54.57%, down from 57.45% year-on-year and below the industry average of 70.17%, suggesting room for improvement in profitability [3]. Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders increased by 14.63% to 3,682, with an average holding of 30,800 shares, up 27.96% [5]. - Notable changes among the top ten circulating shareholders include increases in holdings by several funds, indicating growing investor interest [5]. Group 5: Future Outlook - Aopumai is expected to see revenue growth in the coming years, with projected revenues of 379 million yuan, 473 million yuan, and 586 million yuan for 2025, 2026, and 2027, respectively [5]. - The net profit forecasts for the same years are 87 million yuan, 107 million yuan, and 134 million yuan, reflecting a positive growth trajectory [5].
优利德前三季度营收9.23亿元同比增8.10%,归母净利润1.35亿元同比降10.87%,毛利率下降1.85个百分点
Xin Lang Cai Jing· 2025-10-30 10:49
Core Viewpoint - The financial report for the first three quarters of 2025 indicates a mixed performance for the company, with revenue growth but a decline in net profit and profitability margins [1][2]. Financial Performance - The company's revenue for the first three quarters reached 923 million yuan, representing an 8.10% year-on-year increase [1]. - The net profit attributable to shareholders was 135 million yuan, down 10.87% year-on-year, while the net profit excluding non-recurring items was 130 million yuan, a decrease of 10.25% [1][2]. - Basic earnings per share stood at 1.22 yuan [1][2]. Profitability Metrics - The gross margin for the first three quarters was 42.98%, a decline of 1.85 percentage points year-on-year [2]. - The net profit margin was 13.99%, down 3.43 percentage points compared to the same period last year [2]. - In Q3 2025, the gross margin was 43.75%, showing a year-on-year decrease of 1.23 percentage points but a quarter-on-quarter increase of 1.54 percentage points [2]. Expense Analysis - Total operating expenses for Q3 2025 amounted to 245 million yuan, an increase of 38.99 million yuan year-on-year [2]. - The expense ratio was 26.54%, up 2.42 percentage points from the previous year [2]. - Breakdown of expenses showed sales expenses increased by 8.61%, management expenses by 21.44%, R&D expenses by 21.29%, and financial expenses by 37.49% [2]. Shareholder Information - As of the end of Q3 2025, the total number of shareholders was 6,593, an increase of 898 (15.77%) from the end of the previous half [2]. - The average market value per shareholder decreased from 658,500 yuan to 608,500 yuan, a decline of 7.60% [2]. Company Overview - The company, established on December 5, 2003, and listed on February 1, 2021, is located in Dongguan, Guangdong Province, specializing in the R&D, production, and sales of testing and measurement instruments [3]. - The main business revenue composition includes general instruments (55.97%), temperature and environmental testing instruments (19.20%), testing instruments (14.16%), professional instruments (10.20%), and others (0.46%) [3]. - The company belongs to the machinery equipment sector, specifically in general equipment and instruments [3].
天振股份的前世今生:2025年三季度营收12亿行业排第7,低于行业平均7.45亿元
Xin Lang Cai Jing· 2025-10-30 09:51
Core Viewpoint - Tianzhen Co., Ltd. is a significant player in the global new PVC composite flooring industry, focusing on the research, production, and sales of innovative PVC composite flooring products, with advanced production technology and a full industry chain advantage [1] Group 1: Business Performance - In Q3 2025, Tianzhen achieved a revenue of 1.2 billion yuan, ranking 7th among 13 companies in the industry [2] - The company's net profit for the same period was 85.24 million yuan, placing it 6th in the industry [2] - The revenue breakdown includes SPC flooring at 457 million yuan (57.42%), WPC flooring at 160 million yuan (20.05%), RPET flooring at 129 million yuan (16.26%), LVT flooring at 36.11 million yuan (4.54%), and other products at 13.76 million yuan (1.73%) [2] Group 2: Financial Ratios - As of Q3 2025, Tianzhen's debt-to-asset ratio was 8.04%, significantly lower than the industry average of 39.52%, indicating strong solvency [3] - The gross profit margin for the same period was 17.85%, which is below the industry average of 23.08% [3] Group 3: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 3.02% to 14,900 [5] - The average number of circulating A-shares held per shareholder increased by 3.11% to 3,690.91 [5] - Major shareholders include Huaxia Xingyang One-Year Holding Mixed Fund, which reduced its holdings by 547,400 shares [5]
立讯精密股价跌5.16%,浙商证券资管旗下1只基金重仓,持有2.75万股浮亏损失9.54万元
Xin Lang Cai Jing· 2025-10-30 06:26
Core Viewpoint - Luxshare Precision experienced a decline of 5.16% in stock price, reaching 63.81 CNY per share, with a trading volume of 9.878 billion CNY and a turnover rate of 2.08%, resulting in a total market capitalization of 464.652 billion CNY [1] Company Overview - Luxshare Precision Industry Co., Ltd. is located in Dongguan, Guangdong Province, China, and was established on May 24, 2004, with its listing date on September 15, 2010 [1] - The company specializes in the research, development, production, and sales of connectors, primarily serving the 3C (computer, communication, consumer electronics), automotive, and communication equipment sectors [1] - The revenue composition of Luxshare Precision is as follows: consumer electronics 78.55%, communication interconnect products and precision components 8.91%, automotive interconnect products and precision components 6.95%, computer interconnect products and precision components 3.93%, and other connectors and businesses 1.65% [1] Fund Holdings - According to data from fund holdings, one fund under Zheshang Securities Asset Management has a significant position in Luxshare Precision [2] - The Zheshang Huijin Transformation Growth Fund (000935) held 27,500 shares in the third quarter, accounting for 3.44% of the fund's net value, making it the sixth-largest holding [2] - The estimated floating loss for the fund today is approximately 95,400 CNY [2] Fund Manager Information - The fund manager of Zheshang Huijin Transformation Growth Fund (000935) is Ma Binbo, who has been in the position for 7 years and 310 days [3] - The total asset size of the fund is 51.796 million CNY, with the best fund return during the tenure being 78.16% and the worst return being -43.63% [3]
金辰股份股价涨5.14%,长城基金旗下1只基金重仓,持有21.91万股浮盈赚取32.43万元
Xin Lang Cai Jing· 2025-10-30 06:26
Core Viewpoint - Jinchen Co., Ltd. has experienced a significant stock price increase, reflecting positive market sentiment and potential growth in the high-end intelligent equipment sector, particularly in photovoltaic component manufacturing [1][2]. Group 1: Company Overview - Jinchen Co., Ltd. is located in Suzhou, Jiangsu Province, and was established on August 30, 2004, with its listing date on October 18, 2017 [1]. - The company's main business involves the research, design, manufacturing, and sales of high-end intelligent equipment, with a revenue composition heavily weighted towards photovoltaic component equipment at 98.13% [1]. Group 2: Stock Performance - As of October 30, the stock price of Jinchen Co., Ltd. rose by 5.14% to 30.25 CNY per share, with a trading volume of 198 million CNY and a turnover rate of 4.90%, leading to a total market capitalization of 4.19 billion CNY [1]. - The stock has seen a continuous increase over five days, with a cumulative gain of 4.05% during this period [1]. Group 3: Fund Holdings - The Great Wall Fund has a significant position in Jinchen Co., Ltd., with its Great Wall China Intelligent Manufacturing Mixed A Fund (001880) increasing its holdings by 9,500 shares in the third quarter, totaling 219,100 shares, which represents 4.58% of the fund's net value [2]. - The fund has achieved a year-to-date return of 36.28%, ranking 2,582 out of 8,152 in its category, and a one-year return of 21.29%, ranking 4,244 out of 8,038 [2].
杰普特股价涨5.05%,瑞达基金旗下1只基金重仓,持有8900股浮盈赚取7.18万元
Xin Lang Cai Jing· 2025-10-30 06:14
Group 1 - Jepter's stock price increased by 5.05% to 167.87 CNY per share, with a trading volume of 445 million CNY and a turnover rate of 2.87%, resulting in a total market capitalization of 15.956 billion CNY [1] - The stock has risen for four consecutive days, with a cumulative increase of 16.63% during this period [1] - Jepter specializes in the research, development, production, and sales of lasers and intelligent equipment for precision testing and micro-processing related to integrated circuits and semiconductor optoelectronic devices [1] Group 2 - The fund "Rida Advanced Manufacturing Mixed Fund A" holds 8,900 shares of Jepter, accounting for 3.71% of the fund's net value, making it the seventh-largest holding [2] - The fund has generated a floating profit of approximately 71,800 CNY today and 202,800 CNY during the four-day increase [2] - The fund has a total asset size of 15.1825 million CNY and has achieved a year-to-date return of 52.16%, ranking 1154 out of 8152 in its category [2] Group 3 - The fund manager of "Rida Advanced Manufacturing Mixed Fund A" is Zhang Xiying, who has been in the position for 1 year and 171 days [3] - Under Zhang's management, the fund has achieved a best return of 99.02% and a worst return of 3.16% [3]
苏美达股价涨5.01%,嘉实基金旗下1只基金重仓,持有3.85万股浮盈赚取2.04万元
Xin Lang Cai Jing· 2025-10-30 05:52
Core Viewpoint - Su Mei Da's stock price increased by 5.01% to 11.11 CNY per share, with a trading volume of 299 million CNY and a turnover rate of 2.09%, resulting in a total market capitalization of 14.518 billion CNY [1] Company Overview - Su Mei Da Co., Ltd. is located at 198 Changjiang Road, Nanjing, Jiangsu Province, established on June 24, 1996, and listed on July 1, 1996. The company operates in two main business segments: industrial chain and supply chain [2] - The industrial chain includes sectors such as consumer goods and environmental protection, with key products/services including textiles, home power products (garden machinery, cleaning machinery, gasoline generators), environmental engineering (wastewater treatment, waste management, soil remediation, kitchen waste treatment, biodegradable plastic industrial engineering), clean energy (photovoltaic products, engineering, operation and maintenance), and shipbuilding and shipping [2] - The supply chain focuses on integrated services for bulk commodity operations and import of electromechanical equipment. The revenue composition is as follows: supply chain 71.59%, industrial chain 28.20%, with advanced manufacturing at 11.86% and consumer goods at 8.65% [2] Fund Holdings - According to data, one fund under Jia Shi Fund has a significant holding in Su Mei Da. The Jia Shi Zhong Zheng 1000 Index Enhanced Initiation A (016776) increased its holdings by 11,800 shares in the third quarter, totaling 38,500 shares, representing 0.93% of the fund's net value, ranking as the fifth-largest holding [3] - The fund has a current scale of 26.8915 million CNY and has achieved a year-to-date return of 36.35%, ranking 1449 out of 4216 in its category, with a one-year return of 37.45%, ranking 1266 out of 3885 [3]
国金证券跌2.01%,成交额3.95亿元,主力资金净流出3180.56万元
Xin Lang Cai Jing· 2025-10-30 05:24
Core Viewpoint - Guojin Securities experienced a stock price decline of 2.01% on October 30, 2023, with a current price of 10.25 yuan per share and a total market capitalization of 38.054 billion yuan [1] Group 1: Stock Performance - Guojin Securities' stock price has increased by 19.05% year-to-date, with a 1.18% rise over the last five trading days, 4.81% over the last 20 days, and 7.78% over the last 60 days [2] - As of June 30, 2025, the company reported a net profit of 1.111 billion yuan, representing a year-on-year growth of 144.19% [2] Group 2: Financial Metrics - The company's main business revenue composition includes wealth management (47.27%), proprietary investment (24.86%), investment banking (9.77%), asset management (7.37%), institutional services (6.62%), and others (5.19%) [2] - Guojin Securities has distributed a total of 2.86 billion yuan in dividends since its A-share listing, with 1.108 billion yuan distributed in the last three years [3] Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 4.95% to 145,200, while the average circulating shares per person increased by 22.07% to 25,576 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 141 million shares, an increase of 7.211 million shares from the previous period [3]
精工钢构股价涨5.25%,中欧基金旗下1只基金重仓,持有942.92万股浮盈赚取207.44万元
Xin Lang Cai Jing· 2025-10-30 05:17
Group 1 - The core viewpoint of the news is that Jinggong Steel Structure has seen a significant increase in its stock price, rising 5.25% to 4.41 yuan per share, with a total market capitalization of 8.776 billion yuan as of October 30 [1] - Jinggong Steel Structure has experienced a continuous increase in stock price for four consecutive days, with a cumulative increase of 2.2% during this period [1] - The company specializes in the design, manufacturing, installation, and engineering services of steel structure buildings, with 92.32% of its revenue coming from the steel structure industry [1] Group 2 - The fund under China Europe Fund, specifically the China Europe Value Selection Mixed A (021181), has entered the top ten circulating shareholders of Jinggong Steel Structure, holding 9.4292 million shares, which accounts for 0.47% of the circulating shares [2] - The fund has achieved a year-to-date return of 27.36% and a one-year return of 27.9%, ranking 3705 out of 8152 and 3340 out of 8038 respectively among its peers [2] - The fund manager, Zhang Xueming, has a tenure of 1 year and 191 days, with the best fund return during this period being 71.31% [2] Group 3 - The China Europe Value Selection Mixed A (021181) fund holds 9.4292 million shares of Jinggong Steel Structure, making it the sixth largest holding in the fund, representing 1.89% of the fund's net value [3] - The fund has realized a floating profit of approximately 2.0744 million yuan today, with a floating profit of 848,600 yuan during the four-day stock price increase [3]
方盛制药跌2.06%,成交额6688.86万元,主力资金净流出658.56万元
Xin Lang Cai Jing· 2025-10-30 05:15
Core Viewpoint - Fangsheng Pharmaceutical's stock has experienced fluctuations, with a year-to-date increase of 23.28% and a recent decline of 2.06% on October 30, 2023, indicating market volatility and investor sentiment [1][2]. Financial Performance - For the period from January to September 2025, Fangsheng Pharmaceutical reported a revenue of 1.253 billion yuan, a year-on-year decrease of 7.02%, while the net profit attributable to shareholders increased by 17.60% to 268 million yuan [2]. - Cumulatively, the company has distributed 689 million yuan in dividends since its A-share listing, with 444 million yuan distributed over the past three years [3]. Shareholder Structure - As of September 30, 2025, the number of shareholders decreased by 6.50% to 31,000, while the average circulating shares per person increased by 6.96% to 14,167 shares [2]. - Notable changes in institutional holdings include the entry of new shareholders such as Rongtong China Wind No. 1 Flexible Allocation Mixed Fund and Changxin Jinli Trend Mixed Fund, while previous major shareholders like Industrial Bank Medical Care Stock have exited the top ten [3]. Market Activity - On October 30, 2023, Fangsheng Pharmaceutical's stock price was 12.34 yuan per share, with a trading volume of 66.89 million yuan and a turnover rate of 1.23%, reflecting active market participation [1]. - The stock has seen a net outflow of 6.5856 million yuan from major funds, indicating a cautious approach from institutional investors [1].